Coherus Biosciences | CHRS - Ebitda

Aktienkurs
1.68
Täglich Wechseln
0.03 1.82%
Monatlich
-5.62%
Jährlich
100.98%
Q2 Prognose
1.63




Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 100.31M 21.24M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Baxter International USD 426M 36M 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Fujifilm JPY 132.72B 8.92B 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Merck USD 8.39B 1.97B 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Xencor USD -51.05M 55.28M 2025-12
Zoetis USD 1.04B 87M 2025-09